U.S. Markets open in 9 hrs 8 mins

Esperite N.V. (ESP.AS)

Amsterdam - Amsterdam Delayed Price. Currency in EUR
Add to watchlist
0.429-0.004 (-0.924%)
At close: 5:35PM CEST

Esperite N.V.

Piet Heinstraat 11a
Zutphen 7204 JN
31 575 548 998

Full Time Employees187

Key Executives

Mr. Frédéric AmarChief Exec. Officer and Exec. Director533kN/A53
Henk L. HakvoortFin. DirectorN/AN/AN/A
Aurelie MartinHead of MarketingN/AN/AN/A
Karol KindyHR Mang.N/AN/AN/A
Dr. Ramesh BhondeChief Technical Officer of Indian regionN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Esperite N.V., together with its subsidiaries, operates as a family stem cell bank in Spain, Italy, and internationally. It operates through four segments: Stem Cell, The Cell Factory, Genoma, and Other. The company collects, processes, and stores human adult stem cells from the umbilical cord blood and the umbilical cord tissue. It also provides proteomics and genomics predictive medicine; implements its own proprietary new technology for clinical grade production of autologous mesenchymal and stromal stem cells; and offers cytogenetic analysis through next generation sequencing platforms. The company’s products portfolio includes Tranquility, a non-invasive prenatal test that detects fetal chromosomal abnormalities utilizing a single blood draw from the mother; and Verity, a test for the inborn errors of metabolism of newborns and children utilizing the gas chromatography/mass spectrometry technology. The company was formerly known as Cryo-Save Group N.V. and changed its name to Esperite N.V. in July 2014. Esperite N.V. was founded in 2000 and is based in Zutphen, the Netherlands.

Corporate Governance

Esperite N.V.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.